InsidersTradesSigma
Browse the full insider trade history of Algernon Pharmaceuticals Inc., a listed issuer based in Canada. Shares are quoted on CA CA, under the authority of SEDI. The latest transaction was disclosed on 2 August 2024 (16 - Acquisition or disposition under a prospectus exemption). Among the most active insiders: Moreau, Christopher. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Algernon Pharmaceuticals Inc. is a biopharmaceutical company focused on developing new treatments for serious diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.